References
- Schmidt-Hieber M, Labopin M, Beelen D, et al. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT. Blood 2013;122:3359–3364.
- Einsele H, Ehninger G, Steidle M, et al. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 1993;82: 1672–1678.
- Elmaagacli AH, Steckel NK, Koldehoff M, et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011;118:1402–1412.
- Capria S, Gentile G, Capobianchi A, et al. Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia. J Med Virol 2010; 82: 1201–1207.
- Erlach KC, Böhm V, Seckert CK, et al. Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection. J Virol 2006;80:4801–4819
- Halme L, Lempinen M, Arola J, et al. High frequency of gastroduodenal cytomegalovirus infection in liver transplant patients. APMIS 2008;116:99–106.
- Chiou S-H, Yang Y-P, Lin J-C, et al. The immediate early 2 protein of human cytomegalovirus (HHCMV) mediates the apoptotic control in HHCMV retinitis through up-regulation of the cellular FLICE-inhibitory protein expression. J Immunol 2006;177:6199–6206.
- McCormick AL, Roback L, Mocarski ES. HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog 2008 May 9;4(5):e1000063. doi: 10.1371/journal.ppat.1000063
- von Laer D, Meyer-Koenig U, Serr A, et al. Detection of cytomegalovirus DNA in CD34 + cells from blood and bone marrow. Blood 1995;86:4086–4090.
- Meyer-König U, Hufert FT, von Laer DM. Infection of blood and bone marrow cells with the human cytomegalovirus in vivo. Leuk Lymphoma 1997;25:445–454.
- Sinclair J, Reeves M. The intimate relationship between human cytomegalovirus and the dendritic cell lineage. Front Microbiol 2014;5:389. doi: 10.3389/fmicb.2014.00389. eCollection 2014
- Juckem LK, Boehme KW, Feire AL, et al. Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. J Immunol 2008;180:4965–4977.
- Le VT, Trilling M, Wilborn M, et al. Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol 2008;89:2416–2426.
- Andoniou CE, Degli-Esposti MA. Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. Immunol Cell Biol 2006;84:99–106.
- Goldmacher VS. Cell death suppression by cytomegaloviruses. Apoptosis 2005;10:251–65.
- Tse CM, Levine SA, Yun CH, et al. Na+/H+ exchanger-2 is an O-linked but not an N-linked sialoglycoprotein. Biochemistry 1994;33:12954–12961.
- Elmaagacli AH, Koldehoff M, Zakrzewski JL, et al. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate. Br J Haematol 2007;136:212–219.
- Elmaagacli AH, Koldehoff M, Beelen DW. Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9. Bone Marrow Transplant 2009;44:295–302.
- Dormoy-Raclet V, Markovits J, Malato Y, et al. Unr, a cytoplasmic RNA-binding protein with cold-shock domains, is involved in control of apoptosis in ES and HuH7 cells. Oncogene 2007;26: 2595–2605.
- Scuto A, Kirschbaum M, Kowolik C, et al. The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells. Blood 2008;111:5093–5100.
- Li J, Song W, Czerwinski DK, et al. Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself. J Immunol 2007;179:2493–2500.
- Blazar BR, Krieg AM, Taylor PA. Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients. Blood 2001;98:1217–1225.
- Reid GS, She K, Terrett L, et al. CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response. Blood 2005;105:3641–3647.
- Elmaagacli AH. Molecular methods used for detection of minimal residual disease following hematopoietic stem cell transplantation in myeloid disorders. Methods Mol Med 2014;1109:187–207.
- Lee K, Jeon K, Kim JM, et al. Downregulation of GFAP, TSP-1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus. Glia 2005;51:1–12.
- Koldehoff M, Beelen DW, Elmaagacli AH. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma. J Leukoc Biol 2008;84:561–576.
- Koldehoff M, Zakrzewski JL, Klein-Hitpass L, et al. Gene profiling of growth factor independence 1B gene (Gfi-1B) in leukemic cells. Int J Hematol 2008;87:39–47.
- Poncet D, Pauleau AL, Szabadkai G, et al. Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. J Cell Biol 2006;174:985–996.
- Arnoult D, Bartle LM, Skaletskaya A, et al. Cytomegalovirus cell death suppressor vMIA blocks Bax – but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc Natl Acad Sci USA 2004;101:7988–7993.
- Wiebusch L, Neuwirth A, Grabenhenrich L, et al. Cell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells. J Virol 2008;82: 10188–10198.
- Reboredo M, Greaves RF, Hahn G. Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J Gen Virol 2004;85:3555–3567.
- Boeckh M, Murphy WJ, Peggs KS. Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biol Blood Marrow Transplant 2015;21:24–29.
- Varani S1, Cederarv M, Feld S, et al. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J Immunol 2007;179:7767–7776.
- Hoffman B, Liebermann DA. Gadd45 in modulation of solid tumors and leukemia. Adv Exp Med Biol 2013;793:21–33.